Intas Pharmaceuticals in South Africa

Intas Pharmaceuticals Expands Presence in South Africa with Strategic Appointment

Johannesburg, South Africa – April 9, 2025

Intas Pharmaceuticals, a leading multinational pharmaceutical company, has appointed Parthiv Mehta as Vice President – Rest of Africa & International Fertility. This strategic move underscores Intas’ commitment to enhancing its footprint in the African market, including South Africa, and strengthening its position in the global fertility sector. (medicaldialogues.in)

Parthiv Mehta brings over 25 years of experience in pharmaceutical marketing and business development, with a strong focus on strategic business models that unlock market opportunities across Africa and the Middle East. His proven track record in launching new products and building strong brands in these regions will be instrumental in driving Intas’ ambitious goals forward. (medicaldialogues.in)

Prior to joining Intas, Mehta held significant roles at Glenmark Pharmaceuticals, including Head of East Africa, where he led commercial operations and growth strategies across a highly competitive market landscape. His earlier roles at Tata International Limited and Dr. Reddy’s Laboratories further demonstrate his ability to scale brands and penetrate new markets. (hrtoday.in)

This appointment aligns with Intas’ strategic initiatives to expand its presence in the African pharmaceutical market and enhance its offerings in the fertility treatment domain. The company remains committed to providing high-quality, affordable healthcare solutions to patients across South Africa and the broader African continent.

Intas Pharmaceuticals continues to strengthen its global operations, focusing on strategic leadership appointments and partnerships to drive growth and innovation in key markets.